Adam George, PharmD, serves as the Vice President of Regulatory Affairs at OncoVerity, bringing over 15 years of experience in oncology clinical drug development and regulatory affairs. He has held senior positions at PureTech Health, LLC and Teva Pharmaceuticals. In his previous role at the FDA, Adam managed the clinical review of INDs, NDAs, and BLAs for hematologic malignancies, including AML, and also led regulatory advertising, promotional materials, and product labeling in the FDA Office of Prescription Drug Promotion (OPDP).